It was reported that the patient passed away due to a failure to thrive.The patient experienced stroke like symptoms approximately postoperative delirium (pod) on (b)(6) 2023.As a result of this the patient had a complicated post operative course that limited their ability to rehabilitate physically.As such, the patient was unable to reach good quality of life and was eventually considered failure to thrive.A family meeting led to the decision to withdraw care which eventually occurred on (b)(6) 2023, and the patient passed away shortly thereafter.The outcome was not device or therapy related; the device operated as intended.The device was not explanted.
|
A direct correlation between heartrate 3 left ventricular assist system (lvas), serial number mlp-(b)(6) and the patient¿s outcome could not be conclusively established through this evaluation.Multiple attempts were made to obtain additional information from the customer regarding the event; however, no additional information was provided.The relevant sections of the device history records for mlp-(b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartrate 3 left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1, ¿introduction¿, lists potential adverse events that may be associated with the use of the heartmate 3 lvas, including other neurological events (not stroke-related), stroke, and death.Section 6 of the ifu, ¿patient care and management¿ provides information regarding anticoagulation, including the recommended inr (international normalized ratio) values.No further information was provided.The manufacturer is closing the file on this event.
|